Search Results - "Hennrich, Ute"

Lutathera ® : The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy by Hennrich, Ute, Kopka, Klaus

“…As the first radiopharmaceutical for Peptide Receptor Radionuclide Therapy (PRRT), Lutathera was approved by the EMA in 2017 and the FDA in 2018 for the…”
Get full text

[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer by Hennrich, Ute, Eder, Matthias

“…In March 2022, [177Lu]Lu-PSMA-617 (PluvictoTM) was approved by the FDA for the treatment of prostate cancer patients. Until now, the approval has been limited…”
Get full text

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer by Hennrich, Ute, Eder, Matthias

“…For the positron emission tomography (PET) imaging of prostate cancer, radiotracers targeting the prostate-specific membrane antigen (PSMA) are nowadays used…”
Get full text

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer by Eder, Matthias, Neels, Oliver, Müller, Miriam, Bauder-Wüst, Ulrike, Remde, Yvonne, Schäfer, Martin, Hennrich, Ute, Eisenhut, Michael, Afshar-Oromieh, Ali, Haberkorn, Uwe, Kopka, Klaus

“…The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last…”
Get full text

[68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging by Hennrich, Ute, Benešová, Martina

“…In the United States, [68Ga]Ga-DOTA-TOC has been approved by the Food and Drug Administration (FDA) in 2019 as the first 68Ga-radiopharmaceutical for imaging…”
Get full text

Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [ 18 F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer by Katzschmann, Ines, Marx, Heike, Kopka, Klaus, Hennrich, Ute

“…For the PET imaging of prostate cancer, radiotracers targeting the prostate-specific membrane antigen (PSMA) are nowadays used in clinical practice. […”
Get full text

Lu]Lu-PSMA-617 : The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer by Hennrich, Ute, Eder, Matthias

“…In March 2022, [[sup.177] Lu]Lu-PSMA-617 (Pluvicto[sup.TM] ) was approved by the FDA for the treatment of prostate cancer patients. Until now, the approval has…”
Get full text

Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy by Wiessler, Manfred, Hennrich, Ute, Pipkorn, Rüdiger, Waldeck, Waldemar, Cao, Liji, Peter, Jörg, Ehemann, Volker, Semmler, Wolfhard, Lammers, Twan, Braun, Klaus

“…Innovative and personalized therapeutic approaches result from the identification and control of individual aberrantly expressed genes at the transcriptional…”
Get full text

[ 68 Ga]Ga-DOTA-TOC: The First FDA-Approved 68 Ga-Radiopharmaceutical for PET Imaging by Hennrich, Ute, Benešová, Martina

“…In the United States, [ Ga]Ga-DOTA-TOC has been approved by the Food and Drug Administration (FDA) in 2019 as the first Ga-radiopharmaceutical for imaging of…”
Get full text

Improved synthesis strategy for peptide nucleic acids (PNA) appropriate for cell-specific fluorescence imaging by Pipkorn, Rüdiger, Wiessler, Manfred, Waldeck, Waldemar, Hennrich, Ute, Nokihara, Kiyoshi, Beining, Marcel, Braun, Klaus

“…Progress in genomics and proteomics attended to the door for better understanding the recent rapid expanding complex research field of metabolomics. This trend…”
Get full text

BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies by Braun, Klaus, Beining, Marcel, Wiessler, Manfred, Lammers, Twan, Pipkorn, Rüdiger, Hennrich, Ute, Nokihara, Kiyoshi, Semmler, Wolfhard, Debus, Jürgen, Waldeck, Waldemar

“…With the increase in molecular diagnostics and patient-specific therapeutic approaches, the delivery and targeting of imaging molecules and pharmacologically…”
Get full text

Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression by Hennrich, Ute, Seyler, Lisa, Schäfer, Martin, Bauder-Wüst, Ulrike, Eisenhut, Michael, Semmler, Wolfhard, Bäuerle, Tobias

“…The expression of the chemokine receptor CXCR4 in tumors is associated with tumor aggressiveness and poor prognosis for the patient and contributes to…”
Get full text